MediFind found 86 doctor with experience in Neuroendocrine Tumor near New Haven, CT. Of these, 70 are Experienced, 9 are Advanced, 5 are Distinguished and 2 are Elite.
Yale University
Pamela Kunz is an Oncologist in New Haven, Connecticut. Dr. Kunz is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Carcinoid Syndrome, Pancreaticoduodenectomy, and Pancreatectomy.
Irvin Modlin is a General Surgeon in New Haven, Connecticut. Dr. Modlin is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, and Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).
Yale University
Sajid Khan, MD is Associate Professor of Surgery (Oncology), Chief of Hepato-Pancreato-Biliary & Mixed Tumors, Co-Director of Team Science, and Co-Director of Liver Pump Program at Yale School of Medicine. Dr. Khan is internationally recognized for superb clinical care and excellence in cancer research. He earned his medical degree from SUNY Upstate Medical University in Syracuse, NY and is Board Certified in both Complex General Surgical Oncology and General Surgery. He completed general surgery training at Oregon Health & Science University in Portland, OR and Albert Einstein College of Medicine/Montefiore in Bronx, NY. He also completed a research fellowship in surgical oncology at Memorial Sloan-Kettering Cancer Center in New York, NY and a clinical and research fellowship in surgical oncology at University of Chicago Medical Center in Chicago, IL. Dr. Khan is dedicated to improving the lives of cancer patients by his busy surgical practice, federally funded research, leadership by example, collaboration, and kindness.Dr. Khan's complex surgical oncology practice specializes in patients with tumors of the liver, pancreas, bile ducts, stomach, and colon. Additionally he treats individuals diagnosed with melanoma and neuroendocrine tumors. He has performed over 1,800 oncologic surgeries throughout the Yale System. His commitment to his patients and their families incorporates a multidisciplinary team approach, excellent communication, and minimally invasive surgery. Dr. Khan is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Familial Pancreatic Cancer, Stomach Cancer, Melanoma, Splenectomy, and Pancreatectomy.
Yale University
Harry Aslanian is a Gastroenterologist in New Haven, Connecticut. Dr. Aslanian is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Fitz-Hugh-Curtis Syndrome, Chronic Pancreatitis, Hereditary Pancreatitis, Endoscopy, and Colonoscopy.
Yale University
Kiran Turaga is a Surgical Oncologist in New Haven, Connecticut. Dr. Turaga is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pseudomyxoma Peritonei, Colorectal Cancer, Familial Colorectal Cancer, Pancreaticoduodenectomy, and Gastrostomy. Dr. Turaga is currently accepting new patients.
Yale University
Scott Gettinger is an Oncologist and a Hematologist in New Haven, Connecticut. Dr. Gettinger is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Gamma Knife Radiosurgery.
Yale University
Jeremy Kortmansky is a Hematologist Oncology specialist and an Oncologist in New Haven, Connecticut. Dr. Kortmansky is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Gastrostomy.
Yale University
Jill Lacy is an Oncologist in New Haven, Connecticut. Dr. Lacy is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, and Stomach Cancer.
Yale University
Michael Cecchini is a Hematologist Oncology specialist and a Hematologist in New Haven, Connecticut. Dr. Cecchini is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Gastroesophageal Junction Cancer, and Familial Pancreatic Cancer.
Ronald Salem is a Surgical Oncologist and a General Surgeon in New Haven, Connecticut. Dr. Salem is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.
Yale University
Frank Detterbeck is a Thoracic Surgeon and a General Surgeon in New Haven, Connecticut. Dr. Detterbeck is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Thymic Epithelial Tumor, Lung Cancer, Mediastinal Tumor, Thymectomy, and Endoscopy.
Yale University
Harriet Kluger is a Hematologist and an Oncologist in New Haven, Connecticut. Dr. Kluger is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Renal Cell Carcinoma (RCC), Melanoma of the Eye, and Nephrectomy.
Charles Fuchs is an Oncologist and a Hematologist in New Haven, Connecticut. Dr. Fuchs is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Colorectal Cancer, Gastroesophageal Junction Cancer, Stomach Cancer, Pancreaticoduodenectomy, and Colonoscopy.
Yale University
John Kunstman is a Surgical Oncologist and a General Surgeon in New Haven, Connecticut. Dr. Kunstman has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Stomach Cancer, Gastrointestinal Fistula, Pancreaticoduodenectomy, and Pancreatectomy.
Yale University
Kelly Olino is a General Surgeon and a Surgical Oncologist in New Haven, Connecticut. Dr. Olino is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Merkel Cell Carcinoma, Melanoma, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.
Yale University
Anne Chiang is an Oncologist in New Haven, Connecticut. Dr. Chiang is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma.
Yale University
Mario Sznol is a Hematologist and an Oncologist in New Haven, Connecticut. Dr. Sznol has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, and Chromophobe Renal Cell Carcinoma.
Yale University
Thiruvengadam Muniraj is a Gastroenterologist in New Haven, Connecticut. Dr. Muniraj is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Hereditary Pancreatitis, Chronic Pancreatitis, Acute Pancreatitis, Gallbladder Removal, and Endoscopy.
Yale University
Ashita Talsania is an Oncologist and a Hematologist in New Haven, Connecticut. Dr. Talsania is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Myelodysplastic Syndrome (MDS).
Evan Vosburgh is an Oncologist in New Haven, Connecticut. Dr. Vosburgh is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, and Multiple Endocrine Neoplasia Type 1.
Last Updated: 10/30/2025



